| Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints MKB Parmar, V Torri, L Stewart Statistics in medicine 17 (24), 2815-2834, 1998 | 4340 | 1998 |
| Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group JP Pignon, H Tribodet, GV Scagliotti, JY Douillard, FA Shepherd, ... Journal of clinical oncology 26 (21), 3552-3559, 2008 | 2902 | 2008 |
| Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial PB Panici, S Basile, F Maneschi, AA Lissoni, M Signorelli, G Scambia, ... JNCI: Journal of the National Cancer Institute 100 (23), 1707-1716, 2008 | 1892 | 2008 |
| Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer DJ Sargent, S Marsoni, G Monges, SN Thibodeau, R Labianca, ... Journal of clinical oncology 28 (20), 3219-3226, 2010 | 1822 | 2010 |
| Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of … A Sartore-Bianchi, L Trusolino, C Martino, K Bencardino, S Lonardi, ... The Lancet Oncology 17 (6), 738-746, 2016 | 991 | 2016 |
| Duration of adjuvant chemotherapy for stage III colon cancer A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ... New England Journal of Medicine 378 (13), 1177-1188, 2018 | 965 | 2018 |
| Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non–small-cell lung cancer GV Scagliotti, R Fossati, V Torri, L Crino, G Giaccone, G Silvano, ... Journal of the National Cancer Institute 95 (19), 1453-1461, 2003 | 826 | 2003 |
| Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. R Fossati, C Confalonieri, V Torri, E Ghislandi, A Penna, V Pistotti, ... Journal of clinical oncology 16 (10), 3439-3460, 1998 | 731 | 1998 |
| COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study MC Garassino, JG Whisenant, LC Huang, A Trama, V Torri, F Agustoni, ... The Lancet Oncology 21 (7), 914-922, 2020 | 665 | 2020 |
| Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials E Mitry, ALA Fields, H Bleiberg, R Labianca, G Portier, D Tu, D Nitti, ... Journal of clinical oncology 26 (30), 4906-4911, 2008 | 662 | 2008 |
| Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial MC Garassino, O Martelli, M Broggini, G Farina, S Veronese, E Rulli, ... The lancet oncology 14 (10), 981-988, 2013 | 588 | 2013 |
| Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial P Ghezzi, S Magnanini, M Rinaldini, F Berardi, G Di Biagio, F Testare, ... Jama 271 (20), 1587-1592, 1994 | 577 | 1994 |
| Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials: A study of the GISCAD (Gruppo Italiano per lo … E Mari, I Floriani, A Tinazzi, A Buda, M Belfiglio, M Valentini, S Cascinu, ... Annals of Oncology 11 (7), 837-843, 2000 | 559 | 2000 |
| Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care R D'Amico, S Pifferi, V Torri, L Brazzi, E Parmelli Cochrane Database of Systematic Reviews, 2009 | 553 | 2009 |
| Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the … AJM Ferreri, K Cwynarski, E Pulczynski, M Ponzoni, M Deckert, LS Politi, ... The Lancet Haematology 3 (5), e217-e227, 2016 | 551 | 2016 |
| Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials R D'Amico, S Pifferi, C Leonetti, V Torri, A Tinazzi, A Liberati Bmj 316 (7140), 1275-1285, 1998 | 533 | 1998 |
| Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients B Muller, G Peri, A Doni, V Torri, R Landmann, B Bottazzi, A Mantovani Critical care medicine 29 (7), 1404-1407, 2001 | 441 | 2001 |
| Antibody–Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non–small cell lung cancer subsequent to PD-1/PD-L1 blockade G Lo Russo, M Moro, M Sommariva, V Cancila, M Boeri, G Centonze, ... Clinical Cancer Research 25 (3), 989-999, 2019 | 396 | 2019 |
| Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer G Selvaggi, S Novello, V Torri, E Leonardo, P De Giuli, P Borasio, ... Annals of oncology 15 (1), 28-32, 2004 | 373 | 2004 |
| Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis A Maggioni, P Benedetti Panici, T Dell'Anna, F Landoni, A Lissoni, ... British journal of cancer 95 (6), 699-704, 2006 | 369 | 2006 |
